▶ 調査レポート

世界の皮下注用免疫グロブリン製剤産業2020-2026

• 英文タイトル:Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界の皮下注用免疫グロブリン製剤産業2020-2026 / Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3013232資料のイメージです。• レポートコード:D0MA3013232
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥509,600 (USD4,900)▷ お問い合わせ
  Multi User¥764,400 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,019,200 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、皮下注用免疫グロブリン製剤の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、皮下注用免疫グロブリン製剤のグローバル市場動向、メーカー別競争状況、種類別市場規模(純度10%、純度20%)、用途別市場規模(原発性免疫不全症、二次性免疫不全症、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・皮下注用免疫グロブリン製剤の種類別市場2015-2026:純度10%、純度20%
・皮下注用免疫グロブリン製剤の用途別市場2015-2026:原発性免疫不全症、二次性免疫不全症、その他
・皮下注用免疫グロブリン製剤の北米市場分析
・皮下注用免疫グロブリン製剤のアジア市場分析
・皮下注用免疫グロブリン製剤の中南米市場分析
・皮下注用免疫グロブリン製剤の中東・アフリカ市場分析
・関連企業情報:Shire (Baxalta)、Grifols、CSL
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.
In 2019, the global Subcutaneous Immunoglobulins market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Subcutaneous Immunoglobulins.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Subcutaneous Immunoglobulins market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Subcutaneous Immunoglobulins market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Subcutaneous Immunoglobulins market. Readers of the report can become informed about current and future trends of the global Subcutaneous Immunoglobulins market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Subcutaneous Immunoglobulins markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Subcutaneous Immunoglobulins market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Subcutaneous Immunoglobulins market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Subcutaneous Immunoglobulins market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Subcutaneous Immunoglobulins market is segmented into
10% Purity
20% Purity

Market Segment by Application, the Subcutaneous Immunoglobulins market is segmented into
Primary Immunodeficiency
Secondary Immunodeficiency
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Shire (Baxalta)
Grifols
CSL

The study objectives are:
To analyze and research the global Subcutaneous Immunoglobulins status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Subcutaneous Immunoglobulins manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Subcutaneous Immunoglobulins are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Subcutaneous Immunoglobulins Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Subcutaneous Immunoglobulins Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 10% Purity
1.3.3 20% Purity
1.4 Market Segment by Application
1.4.1 Global Subcutaneous Immunoglobulins Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Primary Immunodeficiency
1.4.3 Secondary Immunodeficiency
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Subcutaneous Immunoglobulins Revenue (2015-2026)
2.1.1 Global Subcutaneous Immunoglobulins Revenue (2015-2026)
2.1.2 Global Subcutaneous Immunoglobulins Sales (2015-2026)
2.2 Subcutaneous Immunoglobulins Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Subcutaneous Immunoglobulins Sales by Regions (2015-2020)
2.2.2 Global Subcutaneous Immunoglobulins Revenue by Regions (2015-2020)
2.3 Global Top Subcutaneous Immunoglobulins Regions (Countries) Ranking by Market Size
2.4 Subcutaneous Immunoglobulins Industry Trends
2.4.1 Subcutaneous Immunoglobulins Market Top Trends
2.4.2 Market Drivers
2.4.3 Subcutaneous Immunoglobulins Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Subcutaneous Immunoglobulins Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Subcutaneous Immunoglobulins Manufacturers by Sales (2015-2020)
3.1.1 Global Subcutaneous Immunoglobulins Sales by Manufacturers (2015-2020)
3.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Subcutaneous Immunoglobulins Sales in 2019
3.2 Global Top Manufacturers Subcutaneous Immunoglobulins by Revenue
3.2.1 Global Subcutaneous Immunoglobulins Revenue by Manufacturers (2015-2020)
3.2.2 Global Subcutaneous Immunoglobulins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Subcutaneous Immunoglobulins Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunoglobulins as of 2019)
3.4 Global Subcutaneous Immunoglobulins Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Subcutaneous Immunoglobulins Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Subcutaneous Immunoglobulins Market
3.7 Key Manufacturers Subcutaneous Immunoglobulins Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Subcutaneous Immunoglobulins Historic Market Review by Type (2015-2020)
4.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Type (2015-2020)
4.1.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Type (2015-2020)
4.1.4 Subcutaneous Immunoglobulins Price by Type (2015-2020)
4.1 Global Subcutaneous Immunoglobulins Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Subcutaneous Immunoglobulins Sales Forecast by Type (2021-2026)
4.2.3 Global Subcutaneous Immunoglobulins Revenue Forecast by Type (2021-2026)
4.2.4 Subcutaneous Immunoglobulins Price Forecast by Type (2021-2026)

5 Global Subcutaneous Immunoglobulins Market Size by Application
5.1 Global Subcutaneous Immunoglobulins Historic Market Review by Application (2015-2020)
5.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2015-2020)
5.1.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2015-2020)
5.1.4 Subcutaneous Immunoglobulins Price by Application (2015-2020)
5.2 Global Subcutaneous Immunoglobulins Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Subcutaneous Immunoglobulins Sales Forecast by Application (2021-2026)
5.2.3 Global Subcutaneous Immunoglobulins Revenue Forecast by Application (2021-2026)
5.2.4 Subcutaneous Immunoglobulins Price Forecast by Application (2021-2026)

6 North America
6.1 North America Subcutaneous Immunoglobulins Breakdown Data by Company
6.2 North America Subcutaneous Immunoglobulins Breakdown Data by Type
6.3 North America Subcutaneous Immunoglobulins Breakdown Data by Application
6.4 North America Subcutaneous Immunoglobulins Breakdown Data by Countries
6.4.1 North America Subcutaneous Immunoglobulins Sales by Countries
6.4.2 North America Subcutaneous Immunoglobulins Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Subcutaneous Immunoglobulins Breakdown Data by Company
7.2 Europe Subcutaneous Immunoglobulins Breakdown Data by Type
7.3 Europe Subcutaneous Immunoglobulins Breakdown Data by Application
7.4 Europe Subcutaneous Immunoglobulins Breakdown Data by Countries
7.4.1 Europe Subcutaneous Immunoglobulins Sales by Countries
7.4.2 Europe Subcutaneous Immunoglobulins Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Subcutaneous Immunoglobulins Breakdown Data by Company
8.2 Asia Pacific Subcutaneous Immunoglobulins Breakdown Data by Type
8.3 Asia Pacific Subcutaneous Immunoglobulins Breakdown Data by Application
8.4 Asia Pacific Subcutaneous Immunoglobulins Breakdown Data by Regions
8.4.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Regions
8.4.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Subcutaneous Immunoglobulins Breakdown Data by Company
9.2 Latin America Subcutaneous Immunoglobulins Breakdown Data by Type
9.3 Latin America Subcutaneous Immunoglobulins Breakdown Data by Application
9.4 Latin America Subcutaneous Immunoglobulins Breakdown Data by Countries
9.4.1 Latin America Subcutaneous Immunoglobulins Sales by Countries
9.4.2 Latin America Subcutaneous Immunoglobulins Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Subcutaneous Immunoglobulins Breakdown Data by Type
10.2 Middle East and Africa Subcutaneous Immunoglobulins Breakdown Data by Application
10.3 Middle East and Africa Subcutaneous Immunoglobulins Breakdown Data by Countries
10.3.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries
10.3.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Shire (Baxalta)
11.1.1 Shire (Baxalta) Corporation Information
11.1.2 Shire (Baxalta) Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Products and Services
11.1.5 Shire (Baxalta) SWOT Analysis
11.1.6 Shire (Baxalta) Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Grifols Subcutaneous Immunoglobulins Products and Services
11.2.5 Grifols SWOT Analysis
11.2.6 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Business Overview and Total Revenue (2019 VS 2018)
11.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 CSL Subcutaneous Immunoglobulins Products and Services
11.3.5 CSL SWOT Analysis
11.3.6 CSL Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Subcutaneous Immunoglobulins Sales Channels
12.2.2 Subcutaneous Immunoglobulins Distributors
12.3 Subcutaneous Immunoglobulins Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Subcutaneous Immunoglobulins Sales Forecast (2021-2026)
13.1.1 Global Subcutaneous Immunoglobulins Sales Forecast by Regions (2021-2026)
13.1.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Subcutaneous Immunoglobulins Sales Forecast (2021-2026)
13.2.2 North America Subcutaneous Immunoglobulins Revenue Forecast (2021-2026)
13.2.3 North America Subcutaneous Immunoglobulins Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Subcutaneous Immunoglobulins Sales Forecast (2021-2026)
13.3.2 Europe Subcutaneous Immunoglobulins Revenue Forecast (2021-2026)
13.3.3 Europe Subcutaneous Immunoglobulins Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Subcutaneous Immunoglobulins Sales Forecast (2021-2026)
13.4.2 Asia Pacific Subcutaneous Immunoglobulins Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Subcutaneous Immunoglobulins Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Subcutaneous Immunoglobulins Sales Forecast (2021-2026)
13.5.2 Latin America Subcutaneous Immunoglobulins Revenue Forecast (2021-2026)
13.5.3 Latin America Subcutaneous Immunoglobulins Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Subcutaneous Immunoglobulins Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Subcutaneous Immunoglobulins Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Subcutaneous Immunoglobulins Key Market Segments
Table 2. Ranking of Global Top Subcutaneous Immunoglobulins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subcutaneous Immunoglobulins Market Size Growth Rate by Type 2021-2026 (K Bottle) & (Million US$)
Table 4. Major Manufacturers of 10% Purity
Table 5. Major Manufacturers of 20% Purity
Table 6. Global Subcutaneous Immunoglobulins Market Share by Application 2019-2025 (K Bottle)
Table 7. Global Subcutaneous Immunoglobulins Market Size by Regions 2015-2020 (K Bottle) & (Million US$)
Table 8. Global Subcutaneous Immunoglobulins Sales by Regions 2015-2020 (K Bottle)
Table 9. Global Subcutaneous Immunoglobulins Sales Market Share by Regions 2015-2020
Table 10. Global Subcutaneous Immunoglobulins Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Subcutaneous Immunoglobulins Revenue Market Share by Regions 2015-2020
Table 12. Top Subcutaneous Immunoglobulins Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Subcutaneous Immunoglobulins Key Drivers: Impact Analysis (2021-2026)
Table 15. Subcutaneous Immunoglobulins Key Challenges
Table 16. Main Points Interviewed from Key Subcutaneous Immunoglobulins Players: Views for Future
Table 17. Global Subcutaneous Immunoglobulins Sales by Manufacturers (2015-2020) (K Bottle)
Table 18. Global Subcutaneous Immunoglobulins Sales Share by Manufacturers (2015-2020)
Table 19. Subcutaneous Immunoglobulins Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Subcutaneous Immunoglobulins Revenue Share by Manufacturers (2015-2020)
Table 21. Global Subcutaneous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunoglobulins as of 2019)
Table 23. Key Manufacturers Subcutaneous Immunoglobulins Average Selling Price (ASP) (2015-2020) (USD/Bottle)
Table 24. Key Manufacturers Subcutaneous Immunoglobulins Plants/Factories Distribution
Table 25. Key Manufacturers Subcutaneous Immunoglobulins Area Served
Table 26. Date of Key Manufacturers Enter into Subcutaneous Immunoglobulins Market
Table 27. Key Manufacturers Subcutaneous Immunoglobulins Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 10% Purity Sales and Revenue (2015-2020) (K Bottle) & (Million US$)
Table 30. Global 20% Purity Sales and Revenue (2015-2020) (K Bottle) & (Million US$)
Table 31. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Type (2015-2020)
Table 32. Global Subcutaneous Immunoglobulins Sales Share by Type (2015-2020)
Table 33. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Subcutaneous Immunoglobulins Price (K Bottle) by Type (2015-2020)
Table 35. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Type (2021-2026)
Table 36. Global Subcutaneous Immunoglobulins Sales Share by Type (2021-2026)
Table 37. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Subcutaneous Immunoglobulins Revenue Share by Type (2021-2026)
Table 39. Global Subcutaneous Immunoglobulins Price (K Bottle) by Type (2021-2026)
Table 40. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Application (2015-2020)
Table 41. Global Subcutaneous Immunoglobulins Sales Share by Application (2015-2020)
Table 42. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Subcutaneous Immunoglobulins Price by Application 2015-2020 (USD/Bottle)
Table 44. Global Subcutaneous Immunoglobulins Sales by Application (2015-2020) (K Bottle)
Table 45. Global Subcutaneous Immunoglobulins Sales Share by Application (2015-2020)
Table 46. Global Subcutaneous Immunoglobulins Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Subcutaneous Immunoglobulins Revenue Share by Application (2021-2026)
Table 48. Global Subcutaneous Immunoglobulins Price (K Bottle) by Application (2021-2026)
Table 49. North America Subcutaneous Immunoglobulins Sales by Company (2015-2020) (K Bottle)
Table 50. North America Subcutaneous Immunoglobulins Sales Market Share by Company (2015-2020)
Table 51. North America Subcutaneous Immunoglobulins Sales by Type (2015-2020) (K Bottle)
Table 52. North America Subcutaneous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 53. North America Subcutaneous Immunoglobulins Sales by Application (2015-2020) (K Bottle)
Table 54. North America Subcutaneous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 55. North America Subcutaneous Immunoglobulins Sales by Countries (2015-2020) (K Bottle)
Table 56. North America Subcutaneous Immunoglobulins Sales Market Share by Countries (2015-2020)
Table 57. North America Subcutaneous Immunoglobulins Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2015-2020)
Table 59. Europe Subcutaneous Immunoglobulins Sales by Company (2015-2020) (K Bottle)
Table 60. Europe Subcutaneous Immunoglobulins Sales Market Share by Company (2015-2020)
Table 61. Europe Subcutaneous Immunoglobulins Sales by Type (2015-2020) (K Bottle)
Table 62. Europe Subcutaneous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 63. Europe Subcutaneous Immunoglobulins Sales by Application (2015-2020) (K Bottle)
Table 64. Europe Subcutaneous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 65. Europe Subcutaneous Immunoglobulins Sales by Countries (2015-2020) (K Bottle)
Table 66. Europe Subcutaneous Immunoglobulins Sales Market Share by Countries (2015-2020)
Table 67. Europe Subcutaneous Immunoglobulins Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Subcutaneous Immunoglobulins Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Subcutaneous Immunoglobulins Sales by Regions (2015-2020) (K Bottle)
Table 70. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Subcutaneous Immunoglobulins Sales by Type (2015-2020) (K Bottle)
Table 72. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Subcutaneous Immunoglobulins Sales by Application (2015-2020) (K Bottle)
Table 74. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Subcutaneous Immunoglobulins Sales by Countries (2015-2020) (K Bottle)
Table 76. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Subcutaneous Immunoglobulins Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Subcutaneous Immunoglobulins Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Subcutaneous Immunoglobulins Sales by Company (2015-2020) (K Bottle)
Table 80. Latin America Subcutaneous Immunoglobulins Sales Market Share by Company (2015-2020)
Table 81. Latin America Subcutaneous Immunoglobulins Sales by Type (2015-2020) (K Bottle)
Table 82. Latin America Subcutaneous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 83. Latin America Subcutaneous Immunoglobulins Sales by Application (2015-2020) (K Bottle)
Table 84. Latin America Subcutaneous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 85. Latin America Subcutaneous Immunoglobulins Sales by Countries (2015-2020) (K Bottle)
Table 86. Latin America Subcutaneous Immunoglobulins Sales Market Share by Countries (2015-2020)
Table 87. Latin America Subcutaneous Immunoglobulins Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Subcutaneous Immunoglobulins Sales by Type (2015-2020) (K Bottle)
Table 90. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2015-2020) (K Bottle)
Table 92. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2015-2020) (K Bottle)
Table 94. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Countries (2015-2020)
Table 97. Shire (Baxalta) Company Details
Table 98. Shire (Baxalta) Description and Business Overview
Table 99. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 100. Shire (Baxalta) Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020)
Table 101. Shire (Baxalta) Subcutaneous Immunoglobulins Sales Market Share in Global Market
Table 102. Shire (Baxalta) Recent Development
Table 103. Grifols Company Details
Table 104. Grifols Description and Business Overview
Table 105. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 106. Grifols Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020)
Table 107. Grifols Subcutaneous Immunoglobulins Sales Market Share in Global Market
Table 108. Grifols Recent Development
Table 109. CSL Company Details
Table 110. CSL Description and Business Overview
Table 111. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 112. CSL Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020)
Table 113. CSL Subcutaneous Immunoglobulins Sales Market Share in Global Market
Table 114. CSL Recent Development
Table 115. Subcutaneous Immunoglobulins Distributors List
Table 116. Subcutaneous Immunoglobulins Customers List
Table 117. Global Subcutaneous Immunoglobulins Sales Forecast 2021-2026 (K Bottle) & (Million US$)
Table 118. Global Subcutaneous Immunoglobulins Sales Forecast by Type 2021-2026 (K Bottle)
Table 119. Global Subcutaneous Immunoglobulins Sales Forecast by Application 2021-2026 (K Bottle)
Table 120. Global Subcutaneous Immunoglobulins Sales Forecast by Regions 2021-2026 (K Bottle)
Table 121. Global Subcutaneous Immunoglobulins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 122. North America Subcutaneous Immunoglobulins Sales Forecast by Countries 2021-2026 (K Bottle)
Table 123. North America Subcutaneous Immunoglobulins Revenue Forecast by Countries 2021-2026
Table 124. Europe Subcutaneous Immunoglobulins Sales Forecast by Countries 2021-2026 (K Bottle)
Table 125. Europe Subcutaneous Immunoglobulins Revenue Market Share Forecast by Countries 2021-2026
Table 126. Asia Pacific Subcutaneous Immunoglobulins Sales Forecast by Regions 2021-2026 (K Bottle)
Table 127. Asia Pacific Subcutaneous Immunoglobulins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 128. Latin America Subcutaneous Immunoglobulins Sales Forecast by Countries 2021-2026 (K Bottle)
Table 129. Latin America Subcutaneous Immunoglobulins Revenue Forecast by Countries 2021-2026 (Million US$)
Table 130. Middle East and Africa Subcutaneous Immunoglobulins Sales Forecast by Regions 2021-2026 (K Bottle)
Table 131. Middle East and Africa Subcutaneous Immunoglobulins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Subcutaneous Immunoglobulins Product Picture
Figure 2. Global Subcutaneous Immunoglobulins Sales Market Shar by Type 2015-2026
Figure 3. 10% Purity Figures
Figure 4. 20% Purity Figures
Figure 5. Global Subcutaneous Immunoglobulins Sales Market Share by Application in 2019 & 2026
Figure 6. Primary Immunodeficiency Use Case
Figure 7. Secondary Immunodeficiency Use Case
Figure 8. Others Use Case
Figure 9. Subcutaneous Immunoglobulins Report Years Considered
Figure 10. Global Subcutaneous Immunoglobulins Market Size 2015-2026 (Million US$)
Figure 11. Global Subcutaneous Immunoglobulins Sales 2015-2020 (K Bottle)
Figure 12. Global Subcutaneous Immunoglobulins Market Size Market Share by Regions 2015-2020
Figure 13. Global Subcutaneous Immunoglobulins Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Subcutaneous Immunoglobulins Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Subcutaneous Immunoglobulins Sales in 2019
Figure 17. Subcutaneous Immunoglobulins Value Share by Manufacturers in 2019
Figure 18. Subcutaneous Immunoglobulins Revenue Share by Manufacturers In 2019
Figure 19. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Subcutaneous Immunoglobulins Revenue Share by Type (2015-2020)
Figure 21. Global Subcutaneous Immunoglobulins Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Subcutaneous Immunoglobulins Market Share by Price Range (2015-2020)
Figure 23. Global Subcutaneous Immunoglobulins Revenue Share by Application (2015-2020)
Figure 24. Global Subcutaneous Immunoglobulins Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Subcutaneous Immunoglobulins Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 27. Canada Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 28. Europe Subcutaneous Immunoglobulins Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 30. France Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 31. U.K. Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 32. Italy Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 33. Russia Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 34. Asia Pacific Subcutaneous Immunoglobulins Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 36. Japan Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 37. South Korea Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 38. India Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 39. Australia Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 40. Taiwan Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 41. Indonesia Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 42. Thailand Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 43. Malaysia Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 44. Philippines Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 45. Vietnam Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 46. Latin America Subcutaneous Immunoglobulins Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 48. Brazil Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 49. Argentina Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 50. Middle East and Africa Subcutaneous Immunoglobulins Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 52. Saudi Arabia Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 53. U.A.E Subcutaneous Immunoglobulins Sales Growth Rate (2015-2020) (K Bottle)
Figure 54. Shire (Baxalta) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Subcutaneous Immunoglobulins Value Chain
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. North America Subcutaneous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 61. North America Subcutaneous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Europe Subcutaneous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 63. Europe Subcutaneous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Asia Pacific Subcutaneous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 65. Asia Pacific Subcutaneous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Latin America Subcutaneous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 67. Latin America Subcutaneous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Middle East and Africa Subcutaneous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 69. Middle East and Africa Subcutaneous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed